PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
76 hedge funds and large institutions have $302M invested in Prevail Therapeutics Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
76
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.6M | |
| 2 | +$11.5M | |
| 3 | +$5.69M | |
| 4 |
Morgan Stanley
New York
|
+$2.78M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.31M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$5.9M | |
| 3 | -$5.47M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.3M |
| 5 |
Jennison Associates
New York
|
-$911K |